You searched for "Endophthalmitis"
Vitreoretinal Disease: Diagnosis, Management and Clinical Pearls (second edition)
A comprehensive, well-illustrated and highly informative resource providing excellent descriptions of vitreoretinal diseases, their presentation, diagnosis and management. The 40 chapters are grouped into four sections, namely: the Anatomy and Physiology of the vitreous, retina, choroid and retinal pigment epithelium;...Boston type I keratoprosthesis for limbal stem cell deficiency
Boston type I keratoprosthesis (KPro) long-term outcomes were compared in patients with and without limbal stem cell deficiency (LSCD) in this retrospective study. In the 11 year period 68 procedures were performed in individuals with LSCD, and 105 procedures in...Bleb-related infection after mitomycin C trabeculectomy
1 October 2014
| Brian Ang
|
EYE - Glaucoma
The authors report on the results of the Collaborative Bleb-related Incidence and Treatment Study (CBIITS), which was a five year multi-centre prospective study designed to investigate the incidence of bleb-related infection following filtering surgery with mitomycin C. In this study,...
Mitomycin C versus 5-FU as an adjunctive treatment for trabeculectomy
1 February 2014
| Anjali Gupta
|
EYE - Glaucoma
Antifibrotic agents are used during trabeculectomy (TRAB) to improve long-term surgical success by reducing fibrosis of subconjunctival and episcleral tissue. The purpose of this meta-analysis was to directly compare the efficacy and safety of the two most frequently used antifibrotic...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
The results of the last survey Apr23
3 April 2023
| Amar Alwitry
|
EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. My thanks...
Feb/Mar 2018 Quiz
History A 48-year-old farmer with gradual worsening vision in her only eye was referred by her optician. She had recently moved to the UK and required an interpreter during consultation. She seemed to have had vision problems since childhood. Although...Prostaglandin associated periorbitopathy
Prostaglandins are known to cause periorbital adverse effects. The aim of this retrospective case series was to compare the frequency of prostaglandin associated periorbitopathy (PAP) between bimatoprost, latanoprost and travoprost users. Five PAP findings were evaluated: upper lid ptosis, deepening...Undetected retinoblastoma management following vitrectomy
5 October 2020
| Annes Ahmeidat
|
Paediatric Ophthalmology / Strabismus
This retrospective study from a single-centre referral university hospital in Germany analysed data collected between 1991-2019 to comment on management and complications of undetected retinoblastoma eyes following vitrectomy. The 10 patients included had a mean age of 36.1 months (range...
Long-term outcomes of intravitreal ranibizumab for neovascular AMD
1 August 2016
| Jonathan Chan
|
Paediatric Ophthalmology / Strabismus
This is a single centre prospective study for the long-term, whole population ‘real-world’ clinical outcomes of ranibizumab therapy in treatment-naïve patients for neovascular age-related macular degeneration (AMD). This study recorded: demographics, Early Treatment Diabetic Retinopathy Study visual acuity (ETDRS VA)...
WATCH EPISODE 12: Beyond 2020 with the Andean Medical Mission
29 January 2025
|
Andean Medical Mission, Charity, International, Working abroad, Dave Goldsmith, LMICs, Rural, South America
Welcome to the 12th episode of Beyond 2020, the video series from Andean Medical Mission | Bolivian Medical Charity that looks at strategies to eliminate avoidable blindness in countries with developing eyecare services and shares ideas and solutions to common...